Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Volume 2 (2005), Issue 3 (March)

1. The FcgammaRIIa-polymorphic site as a potential target for acute graft-versus-host disease in allogeneic stem cell transplantation.
   Biol Blood Marrow Transplant, 11(3): 206-12. [Abstract] [Full-text]
2. Efficacy of caspofungin in prophylaxis and treatment of an adult leukemic patient with invasive pulmonary aspergillosis in allogeneic stem cell transplantation.
   Mycoses, 48(2): 146-8. [Abstract] [Full-text]
3. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
   Clin Cancer Res, 11(4): 1416-24. [Abstract] [Full-text]
4. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells.
   Clin Cancer Res, 11(4): 1372-9. [Abstract] [Full-text]
5. Antileukemic activity of rapamycin in acute myeloid leukemia.
   Blood, 105(6): 2527-34. [Abstract] [Full-text]
6. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells.
   Blood, 105(6): 2428-35. [Abstract] [Full-text]
7. Baalc, a marker of mesoderm and muscle.
   Gene Expr Patterns, 5(4): 463-73. [Abstract] [Full-text]
8. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
   Clin Cancer Res, 11(5): 1821-6. [Abstract] [Full-text]
9. Lovastatin alters the isoprenoid biosynthetic pathway in acute myelogenous leukemia cells in vivo.
   Leuk Res, 29(5): 527-33. [Abstract] [Full-text]
10. Identification of various MLL gene aberrations that lead to MLL gene mutation in patients with acute lymphoblastic leukemia (ALL) and infants with acute leukemia.
    Leuk Res, 29(5): 517-26. [Abstract] [Full-text]
11. Serological identification of immunogenic antigens in acute monocytic leukemia.
    Leuk Res, 29(5): 503-9. [Abstract] [Full-text]
12. Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment.
    Leuk Res, 29(5): 493-501. [Abstract] [Full-text]
13. Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases.
    Ann Hematol, 84(4): 245-9. [Abstract] [Full-text]
14. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
    Ann Hematol, 84(4): 236-44. [Abstract] [Full-text]
15. A phase I/II study of oral etoposide and idarubicin in elderly patients with high-risk acute myeloid leukemia unable to undergo intensive chemotherapy.
    Ann Hematol, 84(4): 227-31. [Abstract] [Full-text]
16. Thyrotoxic crisis induced by cytotoxic chemotherapy.
    Support Care Cancer, 13(3): 196-8. [Abstract] [Full-text]
17. Dacryoadenitis associated with subcutaneous Sweet's syndrome in a patient with acute myeloid leukemia.
    Orbit, 24(1): 55-7. [Abstract] [Full-text]
18. Production of actinium-225 for alpha particle mediated radioimmunotherapy.
    Appl Radiat Isot, 62(5): 667-79. [Abstract] [Full-text]
19. Tuberculosis in allogeneic stem cell transplant recipients: still a problem in the 21st century.
    Transpl Infect Dis, 6(4): 142-6. [Abstract] [Full-text]
20. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group.
    Cancer Epidemiol Biomarkers Prev, 14(3): 651-5. [Abstract] [Full-text]
21. AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion.
    Proc Natl Acad Sci U S A, 102(11): 4016-21. [Abstract] [Full-text]
22. Prognostic index for adult patients with acute myeloid leukemia in first relapse.
    J Clin Oncol, 23(9): 1969-78. [Abstract] [Full-text]
23. Proteomic analysis of interleukin 6-induced differentiation in mouse myeloid leukemia cells.
    Int J Biochem Cell Biol, 37(6): 1197-207. [Abstract] [Full-text]
24. Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia.
    Eur J Haematol, 74(4): 277-81. [Abstract] [Full-text]
25. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).
    Genes Chromosomes Cancer, 43(1): 45-53. [Abstract] [Full-text]
26. 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia.
    Cancer Res, 65(6): 2488-97. [Abstract] [Full-text]
27. Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptide.
    Cancer Res, 65(6): 2373-7. [Abstract] [Full-text]
28. Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations.
    Exp Hematol, 33(4): 469-79. [Abstract] [Full-text]
29. Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study.
    Blood, 105(7): 2664-70. [Abstract] [Full-text]
30. Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11.
    Blood, 105(7): 2900-7. [Abstract] [Full-text]
31. RNAi-induced down-regulation of FLT3 expression in AML cell lines increases sensitivity to MLN518.
    Blood, 105(7): 2952-4. [Abstract] [Full-text]
32. Development of 131I-tositumomab.
    Semin Oncol, 32(1): S50-6. [Abstract] [Full-text]
33. High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia.
    Bone Marrow Transplant, 35(7): 653-61. [Abstract] [Full-text]
34. Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia.
    Clin Cancer Res, 11(6): 2436-44. [Abstract] [Full-text]
35. Cyclosporin A is a broad-spectrum multidrug resistance modulator.
    Clin Cancer Res, 11(6): 2320-6. [Abstract] [Full-text]
36. Immunophenotyping of acute leukaemias.
    Immunol Lett, 98(1): 9-21. [Abstract] [Full-text]
37. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
    J Clin Oncol, 23(10): 2224-32. [Abstract] [Full-text]

© 2004-2008 Acute Myeloid Leukemia Research Today. All Rights Reserved.